Drug Shortage Report for GLN-URSODIOL

Last updated on 2018-01-02 History
Report ID 30985
Drug Identification Number 02426900
Brand name URSODIOL TABLETS USP
Common or Proper name Ursodiol
Company Name GLENMARK PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) URSODIOL
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A05AA
ATC description BILE THERAPY
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-11-29
Actual start date 2017-11-29
Estimated end date 2017-12-15
Actual end date 2018-01-01
Shortage status Resolved
Updated date 2018-01-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1600 STEELES AVE. W., SUITE 407
CONCORD, ONTARIO
CANADA L4K 4M2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-01-02 English Compare
v6 2018-01-01 French Compare
v5 2018-01-01 English Compare
v4 2017-11-30 English Compare
v3 2017-11-28 French Compare
v2 2017-11-28 English Compare
v1 2017-11-28 English Compare

Showing 1 to 7 of 7